David Goldstein
Royal Hospital for Women · 631 works · 30,951 citations · h-index 80
Top works
- Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
- Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
- Cancer Patient Preferences for Communication of Prognosis in the Metastatic Setting
- Initial and Late Resistance to Imatinib in Advanced Gastrointestinal Stromal Tumors Are Predicted by Different Prognostic Factors: A European Organisation for Research and Treatment of Cancer–Italian Sarcoma Group–Australasian Gastrointestinal Trials Group Study
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study
- Desmoplastic Reaction in Pancreatic Cancer
- Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
- A Study on the Transcription of the Polyoma Viral Genome
- Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells
- Remoteness of residence and survival from cancer in New South Wales
- Fertility- and Menopause-Related Information Needs of Younger Women With a Diagnosis of Early Breast Cancer
- Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
- Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types
- Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer. A phase III trial of the National Cancer Institute of Canada Clinical Trials Group [NCIC-CTG]
- Role of Pancreatic Stellate Cells in Pancreatic Cancer Metastasis
- Sex differences in visual-spatial ability: The role of performance factors
- Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer